<DOC>
	<DOCNO>NCT01786369</DOCNO>
	<brief_summary>This screening study aim estimating frequency antipsychotic non-compliance patient history schizophrenia psychotic disorder admit inpatient psychiatric unit . Levels antipsychotic risperidone , olanzapine , quetiapine , aripiprazole , paliperidone drawn patient present emergency room acutely psychotic , require admission inpatient hospital , history psychosis , previously prescribe one study drug . Levels analyze determine frequency severity non-compliance population .</brief_summary>
	<brief_title>Adherence Patients Admitted Psychiatric Unit Acute Psychosis : Analysis Serum Levels Antipsychotics .</brief_title>
	<detailed_description>We hypothesize majority patient admit inpatient psychiatric service acute exacerbation schizophrenia , schizoaffective disorder , bipolar I disorder plasma level antipsychotic low threshold accept therapeutic range determine Arbeitsgemeinschaft fur Neuropsychopharmakologie und Pharmakopsychiatrie ( AGNP ) . We aim estimate frequency total partial non-compliance antipsychotic adult schizophrenia , schizoaffective disorder , bipolar I disorder admitted inpatient psychiatric service psychosis . In order , measure serum level five commonly prescribe antipsychotic ( risperidone , olanzapine , quetiapine , paliperidone aripiprazole ) drawn emergency room set establish degree compliance admit patient . On admission inpatient psychiatry service , blood routinely drawn patient via single venipuncture review basic laboratory value ; 2 tube typically draw . Investigators collect third tube ( approximately 2-3 mLs ) patient prescribe one medication admit psychotic decompensation . This continue 100 patient enrol . The extra blood send determination serum level drug question . Each subject assign unique identification number generate principle investigator , data cod use number . The following data : age , gender , ethnicity , body mass index , specific diagnosis , prescribed dosage drug question obtain subject 's medical record . We use AGNP expert group consensus guideline therapeutic drug monitoring determine degree compliance specific patient . All data obtain information available clinician ( demographic data previous dose ) obtain small additional blood sample . Samples store future use ; residual sample destroy . For purpose exploratory pilot study primarily interested determine proportion patient receive five antipsychotic drug blood level expect therapeutic range . 100 subject permit initial estimate reasonable confidence interval . We also carry exploratory analysis examine relationship lower expect blood level diagnostic demographic patient characteristic . This help inform future research project clinical initiative .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Bipolar Disorder</mesh_term>
	<mesh_term>Psychotic Disorders</mesh_term>
	<mesh_term>Antipsychotic Agents</mesh_term>
	<criteria>18 year older Documented diagnosis schizophrenia , schizoaffective disorder , bipolar 1 disorder Admitted inpatient psychiatric unit Zucker Hillside Hospital psychotic decompensation . Outpatient least one month prior admission On regimen include risperidone , olanzapine , quetiapine , paliperidone aripiprazole Antipsychotic polypharmacy Diagnosis Mental Retardation Pervasive Developmental Disorder Administrations study medication emergency room prior blood draw .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>Schizophrenia</keyword>
	<keyword>Psychotic Disorders</keyword>
	<keyword>Bipolar Disorder</keyword>
	<keyword>Antipsychotic Agents</keyword>
	<keyword>Drug Monitoring</keyword>
</DOC>